Related Experiment Videos
Mitochondrial function impairment induced by amyloid beta-peptide on PC12 cells
C Pereira1, M S Santos, C Oliveira
1Centre for Neuroscience of Coimbra, Faculty of Medicine, University of Coimbra, Portugal.
Abstract:
The aim of the present study was to determine whether amyloid beta-peptide (A beta) induces mitochondrial dysfunction. Mitochondrial function was reported to be affected following A beta exposure, as demonstrated by depolarization of the mitochondrial membrane, decrease of oxygen consumption and by the inhibition of complexes I, III and IV of the mitochondrial respiratory chain. A beta25-35 and A beta1-40 peptides also inhibited MTT reduction in a dose-dependent manner in undifferentiated and differentiated PC12 cells. Several antioxidants prevented this inhibitory response, suggesting that oxidative stress is involved in A beta-induced cytotoxicity. These data suggest that mitochondrial dysfunction contributes to amyloid beta-protein cytotoxicity and may play a major role in the abnormalities of energy metabolism observed in Alzheimer's disease.
Insights
Amyloid beta-peptide (A beta) exposure causes mitochondrial dysfunction, including impaired respiration and reduced cell viability. Antioxidants suggest oxidative stress contributes to this A beta-induced cell damage, relevant to Alzheimer's disease.
Area of Science:
- Neuroscience
- Biochemistry
- Cell Biology
Background:
- Alzheimer's disease (AD) is characterized by amyloid beta-protein (A beta) accumulation.
- Mitochondrial dysfunction is increasingly implicated in AD pathogenesis.
- The direct impact of A beta on mitochondrial function requires further elucidation.
Purpose of the Study:
- To investigate whether amyloid beta-peptide (A beta) directly induces mitochondrial dysfunction.
- To explore the role of oxidative stress in A beta-induced mitochondrial damage.
- To assess the contribution of mitochondrial dysfunction to A beta cytotoxicity.
Main Methods:
- Exposure of PC12 cells (undifferentiated and differentiated) to A beta peptides (A beta25-35 and A beta1-40).
- Assessment of mitochondrial function: membrane potential, oxygen consumption, and respiratory chain complex activity (I, III, IV).
- Measurement of MTT reduction to assess cell viability and the effect of antioxidants.
Main Results:
- A beta exposure led to mitochondrial membrane depolarization and decreased oxygen consumption.
- Inhibition of mitochondrial respiratory chain complexes I, III, and IV was observed.
- A beta peptides inhibited MTT reduction in a dose-dependent manner, which was prevented by antioxidants.
- Oxidative stress is implicated in A beta-induced cytotoxicity.
Conclusions:
- Amyloid beta-peptide induces significant mitochondrial dysfunction.
- Mitochondrial dysfunction and associated oxidative stress contribute to A beta cytotoxicity.
- These findings highlight the critical role of mitochondrial impairment in Alzheimer's disease energy metabolism abnormalities.